These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1414067)

  • 1. [Lupus anticoagulant and antiphospholipid antibody values in a family with systemic lupus erythematosus].
    Alper G; Tavmergen EN; Ozsan H; Tavmergen E; Gümüsdis G; Onat T; Erlacin E
    Zentralbl Gynakol; 1992; 114(10):509-12. PubMed ID: 1414067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
    Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
    Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of beta2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Gushiken FC; Arnett FC; Ahn C; Thiagarajan P
    Arthritis Rheum; 1999 Jun; 42(6):1189-93. PubMed ID: 10366111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.
    Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR
    J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiphospholipid antibodies. Review].
    Diez-Ewald M
    Invest Clin; 1993; 34(3):143-58. PubMed ID: 8155777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies--our experience.
    Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
    Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory.
    Mader R; Ziporen L; Mader R; Neumann L; Buskila D
    Clin Rheumatol; 2002 Sep; 21(5):386-90. PubMed ID: 12223987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
    Triplett DA
    Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.